Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

83%

5 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

5(100.0%)

5Total

Phase 4(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03506113Phase 4Completed

GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

Role: lead

NCT00904566Completed

Validation of 70-gene MammaPrint Profile in Japanese Population

Role: collaborator

NCT00700375Phase 4Completed

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

Role: lead

NCT00716001Phase 4Unknown

Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure

Role: lead

NCT00709774Phase 4Unknown

Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block

Role: lead

NCT00692718Phase 4Unknown

N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

Role: lead

All 6 trials loaded